ArticleFrontiers in oncology2023

A nomogram based on combining clinical features and contrast enhanced ultrasound is not able to identify Her-2 over-expressing cancer from other breast cancers.

Zi-Mei Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.